Clinical Trial Update: A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and immunogenicity of the RVSV-Nipah virus vaccine candidate PHV02 in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nipah Virus Infection

Drugs mentioned

• RVSV-Nipah Virus Vaccine Candidate PHV02 (recombinant vesicular stomatitis virus-based Nipah virus vaccine)

Snippet

Sponsor: Public Health Vaccines LLC | Conditions: Nipah Virus Infection | Phase 1 | Status: COMPLETED